Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Pharmalot
Biotech
Health
The Readout

Biogen’s inkblot & timely stock swaps

  • Damian Garde
  • Meghana Keshavan

By Damian Garde and Meghana Keshavan Dec. 22, 2017

Reprints
The READOUT
Alex Hogan/STAT

The Readout for December 22, 2017

About the Authors Reprints

Damian Garde

Damian Garde

National Biotech Reporter

Damian Garde covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast.

Meghana Keshavan

Meghana Keshavan

Biotech Correspondent

Meghana Keshavan covers biotech and contributes to The Readout newsletter.

Stanford scientist who broke genome sequencing record on what…
Stanford scientist who broke genome sequencing record on what faster diagnoses mean for patients
A national patient ID is essential for patient safety
A national patient ID is essential for patient safety
He Jiankui, embryo editing, CCR5, the London patient, and…
He Jiankui, embryo editing, CCR5, the London patient, and jumping to conclusions
Regeneron targets obesity, a new microbiome deal, & comparing…
Regeneron targets obesity, a new microbiome deal, & comparing cancer drug costs
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries…
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries & regenerating heart tissue
Docs disagree with FDA on Aduhelm, Swiss giants pinch…
Docs disagree with FDA on Aduhelm, Swiss giants pinch pennies, & one SPAC makes it rain

Recommended Stories